Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure.
about
Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis.Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Sofosbuvir-based regimens for the treatment of chronic hepatitis C in severe renal dysfunction.
P2860
Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Sofosbuvir-based antiviral the ...... nts with severe renal failure.
@en
type
label
Sofosbuvir-based antiviral the ...... nts with severe renal failure.
@en
prefLabel
Sofosbuvir-based antiviral the ...... nts with severe renal failure.
@en
P2093
P2860
P50
P356
P1476
Sofosbuvir-based antiviral the ...... nts with severe renal failure.
@en
P2093
Anaïs Vallet-Pichard
Anne Minello
François Bailly
François Habersetzer
Georges-Philippe Pageaux
Jean-Didier Grangé
Jérôme Dumortier
Laurent Alric
Marie-Claude Gagnieu
Olivier Guillaud
P2860
P356
10.1093/NDT/GFW348
P407
P577
2016-10-19T00:00:00Z